ConductScience.org, home

Paper10695900

Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report.

Hollander E and 3 others. J Child Neurol, 2000. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report. Papers, record 10695900. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10695900

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report.
PubMed
Journal
J Child Neurol
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1.78
iCite
Revised in PubMed
2025-10-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hollander EE
2Kaplan AA
3Cartwright CC
4Reichman DD

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive Agents, Second-GenerationMajor topic
Asperger SyndromeMajor topic
Autistic DisorderMajor topic
CyclohexanolsMajor topic
Adult
Child
Child, Preschool
Diagnosis, Differential
Female
Humans
Male
Retrospective Studies
Venlafaxine Hydrochloride

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
42220936Medical treatment of autism spectrum disorder in children: Current evidence, controversies, and clinical challenges.World J Clin Pediatr2026https://conductscience.org/library/papers/42220936PubMed
40143102Available Treatments for Autism Spectrum Disorder: From Old Strategies to New Options.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40143102PubMed
39817414Exploring pathological targets and advancing pharmacotherapy in autism spectrum disorder: Contributions of glial cells and heavy metals.Histol Histopathol2025https://conductscience.org/library/papers/39817414PubMed
39234404
Case Report: Methylphenidate and venlafaxine improved abdominal nociplastic pain in an adult patient with attention deficit hyperactivity disorder, autism spectrum disorder, and comorbid major depression.
Front Pain Res (Lausanne)2024https://conductscience.org/library/papers/39234404PubMed
24603348Pupillometry reveals a mechanism for the Autism Spectrum Disorder (ASD) advantage in visual tasks.Sci Rep2014https://conductscience.org/library/papers/24603348PubMed
24340297Treatment of cataplexy in a three-year-old using venlafaxine.J Clin Sleep Med2013https://conductscience.org/library/papers/24340297PubMed
24174992Treatment of comorbid anxiety and autism spectrum disorders.Neuropsychiatry (London)2011https://conductscience.org/library/papers/24174992PubMed
24091470The Mechanisms Underlying the ASD Advantage in Visual Search.J Autism Dev Disord2016https://conductscience.org/library/papers/24091470PubMed
23226952Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.Dialogues Clin Neurosci2012https://conductscience.org/library/papers/23226952PubMed
19383215Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta).J Am Assoc Lab Anim Sci2009https://conductscience.org/library/papers/19383215PubMed
18775366Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.Child Adolesc Psychiatr Clin N Am2008https://conductscience.org/library/papers/18775366PubMed
16268664Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.CNS Drugs2005https://conductscience.org/library/papers/16268664PubMed
16189507A heterogeneity-based genome search meta-analysis for autism-spectrum disorders.Mol Psychiatry2006https://conductscience.org/library/papers/16189507PubMed
15584771Pharmacotherapy of pervasive developmental disorders in children and adolescents.CNS Drugs2004https://conductscience.org/library/papers/15584771PubMed
12199134Depression in persons with autism: implications for research and clinical care.J Autism Dev Disord2002https://conductscience.org/library/papers/12199134PubMed
11276404The pathophysiology and treatment of autism.Curr Psychiatry Rep2001https://conductscience.org/library/papers/11276404PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10695900

GET https://conductscience.org/api/papers/v1/10695900/authors